The Agrobacterium tumefaciens VirB11 ATPase is postulated to assemble with VirB proteins and the VirD4 protein into a transport system which is dedicated to the export of oncogenic nucleoprotein particles to plant cells. To gain genetic evidence for interactions between VirB11 and other subunits of this transport system, we screened a PCR-mutagenized virB11 library for alleles that diminish the virulence of the wild-type strain A348. Two classes of alleles displaying negative dominance were identified. One class failed to complement a ⌬virB11 mutation, indicating that the corresponding mutant proteins are nonfunctional. The second class complemented the ⌬virB11 mutation, indicating that the mutant proteins are fully functional in strains devoid of native VirB11. Mutations of both classes of alleles were in codons for residues clustered in two regions of VirB11, both located outside the Walker A nucleotide binding motif. All dominant alleles were suppressed at least to some extent by multicopy expression of the virB9, virB10, and/or virB11 genes. Taken together, results of these investigations indicate that (i) a functional T-complex transporter is composed of more than one VirB11 subunit and (ii) VirB11 undergoes complex formation with VirB9 and VirB10 during transporter biogenesis.
, this transporter in fact recognizes and exports a diversity of nucleoprotein and protein substrates. This list includes DNA apparently of any length as long as it contains a recognition site for processing by the VirD2 endonuclease (34) , the non-self-transmissible IncQ plasmid RSF1010, most likely also as a single-stranded DNA-protein particle (4, 9, 52), the VirE2 single-stranded DNA-binding protein (7, 14, 35) , and VirF, which functions as an important virulence factor for infection of certain plant species (40) . Second, recent studies have shown that the T-complex transporter delivers DNA to many dicotyledonous and monocotyledonous plant species as well as to agrobacteria (3, 25) and yeast (10, 11, 36) recipient cells.
Mechanistic studies of the T-complex transport system are just beginning to emerge. Two cytoplasmic membrane ATPases, VirB4 and VirB11, have been postulated to couple energy via ATP hydrolysis to substrate translocation (15, 46) . Recent genetic studies support the notion that both VirB4 and VirB11 function as homo-or heteromultimers. In the case of virB4, alleles coding for mutants with defects in the Walker A nucleotide binding motif are dominant over wild-type virB4 (5, 24) . In the case of virB11, alleles with equivalent mutations are recessive (39, 49) . However, recent studies in this laboratory showed that an allele expressing only the 3Ј half of virB11 exerts transdominance, leading to the proposal that the Cterminal half of VirB11 possesses a protein interaction domain (39) .
In the present study, we extended our characterization of VirB11 by genetically testing for interactions with other VirB proteins. A set of 11 dominant negative virB11 alleles (numbered 1 to 3 and 5 to 12) was isolated from a PCR-mutagenized virB11 library. Interestingly, these alleles were divisible into two classes on the basis of whether they encoded functional proteins when synthesized in a strain lacking the native form of VirB11. Furthermore, the transport defect phenotypes observed upon synthesis of each of the 11 mutant VirB11 proteins in merodiploid cells were suppressed by overproduction of VirB9, VirB10, and/or VirB11. Based on the results of these studies, it is proposed that VirB11 self-associates and also undergoes complex formation with VirB9 and VirB10 during transporter biogenesis.
MATERIALS AND METHODS

Enzymes and reagents.
Isopropyl-␤-D-thiogalactopyranoside (IPTG), Triton X-100, 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal), nitroblue tetrazolium, carbenicillin, kanamycin, and tetracycline were purchased from Sigma (St. Louis, Mo.). Alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G was from Bio-Rad Laboratories (Hercules, Calif.). AS (3Ј,5Ј-dimethoxy-4Ј-hydroxyacetophenone) was from Aldrich (Milwaukee, Wis.). Restriction endonucleases and Klenow fragment of DNA polymerase I were purchased from New England Biolabs (Beverly, Mass.), Promega (Madison, Wis.), or Gibco-BRL (Grand Island, N.Y.).
Bacterial strains, plasmids, and growth conditions. Table 1 lists the bacterial strains and plasmids used in this study and their relevant characteristics. Growth of E. coli and A. tumefaciens cells was performed as described previously (14) . For analysis of Vir protein content, cells were grown to an optical density at 600 nm (OD 600 ) of 0.5 in MG/L medium (22) with antibiotic selection. A 1-ml culture was pelleted and resuspended in induction medium (22) with 200 M AS at an OD 600 of 0.2. Cells were incubated with shaking at 28°C for 18 h to induce vir gene expression. In A. tumefaciens and E. coli cells, plasmids were maintained by the addition of carbenicillin (100 g/ml), kanamycin (100 g/ml), or tetracycline (7.5 g/ml) to the growth medium.
PCR mutagenesis. PCR amplification was performed with a Perkin-Elmer Cetus DNA thermocycler with Taq DNA polymerase from Perkin-Elmer (Madison, Wis.). Oligonucleotides were synthesized with a BioSearch 8600 DNA synthesizer (DNA Core Facility, Department of Microbiology and Molecular 47) . Approximately 10 ng of plasmid pXZB100 was added as a template, and 200 pmol of the oligonucleotides B11Up (5Ј-TGCGAGCTAAGGAGATAACAT) and B11D (5Ј-GAACGTGT GTCGACGGCTCACC) were added as primers. The cycling parameters were 20 cycles of 94°C for 30 s, 55°C for 1 min, and 72°C for 3 min. PCR products from 10 separate amplifications were pooled and digested with BamHI and SalI, and the resulting 1.24-kb fragment containing virB11 was purified by gel isolation and ligated to a gel-isolated vector fragment of similarly digested pXZB100. The ligation mixture was introduced into wild-type strain A348 by electroporation (5).
Transformants were recovered by selection on carbenicillin-and kanamycincontaining MG/L plates and assayed for virulence by inoculation of Kalanchoe daigremontiana leaves as described below. Sequence analysis of transdominant virB11 alleles. Plasmid DNA from merodiploid strains exhibiting avirulence or attenuated virulence was isolated by the boiling miniprep method of Birnboim and Doly as described by Sambrook et al. (42) . A 1.78-kb EcoRI-SalI fragment containing the virB promoter and the presumptively mutated virB11 gene (virB11*) was then subcloned into pBSK ϩ NdeI, resulting in the plasmid pXZ11xx series (Table 1) . DNA sequencing was carried out at the DNA Core Facility of the Department of Microbiology and Molecular Genetics with an ABI 373A DNA Sequencer (Perkin-Elmer) by use of Taq polymerase and primers complementary to sequences distributed at even intervals along the P virB ::virB11 sequence, namely, PvirB (5Ј-AACGCAC TTCTTCCAACG), B11#2 (5Ј-CAGGATGTCGGACCACG), B11#3 (5Ј-GCG TTTCTGCACGCATGC), and B11#4 (5Ј-GCAGCATGGGCTTATCTG).
Protein analysis and immunoblotting. Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (14) . A Tricine-SDS-polyacrylamide gel system was used to visualize low-molecular-weight proteins (43) . Vir proteins were visualized by SDS-PAGE, protein transfer to nitrocellulose membranes, and immunoblot development with goat anti-rabbit antibodies conjugated to alkaline phosphatase (14) . Polyclonal antiserum specificities were previously documented for VirE2 (14) , VirB4 (55), VirB5 (5), VirB7 (22), VirB8 (22) , VirB9 (55), VirB10 (55), and VirB11 (15) antisera. For analysis of Vir protein content, 1 ml of AS-induced culture adjusted to an OD 600 of 0.5 was pelleted by centrifugation, resuspended in a mixture of 50 l of H 2 O and 50 l of protein sample buffer, and immediately boiled for 3 min. VirE2 protein abundance was monitored by immunoblot analysis to ensure that the vir genes were induced equivalently in all strains (6) .
Plasmid constructions for suppression studies. The pXZ11xx plasmids were linearized by digestion with SmaI and ligated to the following BHR plasmids: pED9 (P virB ::virB9, virB10, virB11), pED10 (P virB ::virB10, virB11), pED11 (P virB ::virB11), pJY10 (P virB ::virB10), pXZ90 (P virB ::virB9), pXZ319 (P virB ::virB1 through virB9), and pED52 (P virB ::virB8). The resulting series of plasmids was designated pXZB12xx, pXZB13xx, pXZB14xx, pXZB15xx, pXZB16xx, pXZB17xx, and pXZB18xx, respectively (Table 1) . A. tumefaciens A348 cells transformed with these plasmids were inoculated onto K. daigremontiana leaves to assay for virulence.
Virulence assays.
A. tumefaciens strains were tested for virulence on uniformly wounded K. daigremontiana leaves as described previously (6) . Controls for the tumorigenesis assays included coinoculation of the same leaf with the wild-type strain A348 and avirulent strain A136. Assays were repeated at least five times for each strain on separate leaves. IncP plasmid DNA was isolated from virB11*/ virB11 merodiploid strains that exhibited avirulence or attenuated virulence. These plasmids were reintroduced into strain A348, and the resulting merodiploid strains were assayed at least twice for virulence. All strains were grown identically prior to inoculation of plants, approximately the same numbers of cells were inoculated, and the leaves used in the assays were approximately the same ages. Tumors were photographed 4 to 5 weeks after inoculation.
RESULTS
Isolation of transdominant virB11 alleles. We reasoned that if VirB11 functions as a component of a VirB protein complex, transdominant virB11 alleles may be suppressed by overproduction of VirB proteins that interact with VirB11. To isolate a set of dominant negative virB11 alleles, we assayed the virulence of a total of 3,415 A348 derivatives in which the presumptively mutated virB11* alleles were expressed from an IncP replicon. Eleven merodiploid strains were identified from multiple rounds of screenings that reproducibly exhibited strongly or moderately attenuated virulence (Fig. 1A) . The virB11* alleles were isolated from the corresponding IncP plasmids (pXZB1xx series) and subcloned onto a pBluescript vector (Table 1) . Resulting ColE1 plasmids (pXZ11xx series) were ligated to the BHR plasmid pSW172 for introduction into strain A348. Each transformant displayed a level of virulence comparable to that of the parental A348(pXZB1xx) strain. Results of these studies showed that expression of the virB11* alleles was responsible for the observed T-DNA export defects of virB11*/virB11 merodiploid strains.
Genetic complementation tests showed that the dominant alleles were divisible into two classes (Fig. 1B) . One class of alleles (alleles 1, 3, 8, and 9) failed to complement the ⌬virB11 mutation, as shown by avirulence of the corresponding PC1011 (pXZB1xx) strains (Fig. 1B) . Mutant proteins of this class are designated as nonfunctional. Two additional alleles of this class, virB11F154H;L155M and virB11⌬1-156, were isolated previously (39) . A second class of alleles (alleles 2, 5, 6, 7, 10, 11, and 12) complemented the ⌬virB11 mutation, as shown by restoration of virulence of the corresponding PC1011 (pXZB1xx) strains to wild-type levels (Fig. 1B) . Products of this class of alleles are designated as functional. These proteins appear to display mutant phenotypes only when cosynthesized with native VirB11. Figure 2 depicts three classes of VirB11 mutations isolated to date in this laboratory. Class I mutant proteins possess substitutions in conserved residues in the Walker A nucleotide binding motif; these mutations are recessive and abolish protein function (39) . The class II (dominant, nonfunctional) and class III (dominant, functional) mutant proteins identified in the present study possess one, two, or three amino acid substitutions (Fig. 2 ). Although it is not possible to assign phenotypes to specific mutations in the double and triple mutants, it is of interest that almost all of the mutations code for substitutions that are located within two discrete regions of VirB11, one near the N terminus (residues 49 to 135) and a second near The left sides of leaves were inoculated with strains listed on the extreme left. A348, wild-type strain; A136, Ti plasmidless strain; pXZB95 and pXZB100 express wild-type virB11 ( Table 1 ). The right sides of leaves were inoculated with A348 cells carrying plasmids pXZB101 through pXZB112, which express the mutated virB11* alleles 1 through 12, respectively. A348(pXZB104) cells exhibit wild-type virulence; sequence analysis confirmed that allele 4 possesses no mutations. (B) Virulence assays of PC1011(pXZB1xx) cells. PC1011 is deleted of virB11 from the pTi plasmid (6). 0, strain carrying pXZB100; 1 to 3 and 5 to 12, strains carrying alleles (as numbered) expressed from the pXZB1xx plasmids.
the C terminus (residues 256 to 301), and that both of these regions reside outside of the Walker A nucleotide binding motif.
Abundance of VirB proteins in virB11*/virB11 merodiploid strains. Previous studies in this laboratory established that certain VirB proteins such as VirB7 and VirB9 contribute to the stabilization of other VirB proteins (6, 23) . Conversely, a transdominant VirB7::PhoA41 hybrid protein was shown to have a destabilizing effect on other VirB proteins, most probably by blocking transporter assembly (6, 23, 48) . We examined the potential for the class II or III VirB11 derivatives to disrupt assembly of VirB proteins into a stabilized structure by comparing levels of VirB proteins in A348(pXZB1xx) merodiploid strains, the isogenic strain A348(pXZB100), and wild-type strain A348.
A348(pXZB100) cells accumulated substantially higher levels of VirB11 than did the wild-type A348 cells (Fig. 3) , a result which is consistent with an estimated ϳ5-fold-higher copy number of IncP than of pTi plasmids (7). The A348(pXZB1xx) strains also accumulated higher levels of VirB11 than did the wild-type cells, although for most of these strains, the amount of VirB11 was less than that present in A348(pXZB100) cells. Therefore, corresponding dominant mutations potentially identify residues or domains that affect VirB11 protein stability.
Most A348(pXZB1xx) strains accumulated other VirB proteins detectable by our collection of antisera at or near wildtype levels (Fig. 3) . These findings suggest that synthesis of the class II or III mutant VirB11 proteins does not generally perturb assembly of the VirB proteins into a stabilized structure. Consistent with this finding, previous studies showed that PC1011 cells, which harbor a virB11 null mutation, accumulate abundant levels of other VirB proteins (reference 6 and data not shown).
Suppression of transdominance by overproduction of VirB proteins. We tested for suppression of the dominant phenotypes of the class II and III alleles by overproduction of VirB proteins. Preliminary studies showed that A348 strains carrying pXZB1000, pXZB1200 (P virB ::virB9, virB10, virB11), pXZB1300 (P virB ::virB10, virB11), pXZB1400 (P virB ::virB11), pXZB1500 (P virB ::virB10), pXZB1600 (P virB ::virB9), or pXZB1800 (P virB ::virB8) exhibit wild-type virulence (data not shown). Thus, multicopy expression of these virB genes, which generally is correlated with protein overproduction (see below), does not interfere with delivery of T-complexes to plants. To assess effects of VirB protein overproduction on virulence of virB11*/virB11 strains, the IncP plasmids were ligated to each of the pXZ11xx plasmids, and the resulting plasmid series, pXZB12xx through pXZB18xx (Table 1) , were introduced into A348 cells.
Whereas all 11 A348(pXZB1xx) strains exhibited attenuated virulence, almost all of the strains that expressed a virB11* allele and any combination of the virB9, virB10, or virB11 genes from an IncP plasmid exhibited enhanced virulence (Fig. 4) . The phenotypes of alleles 2, 5, 6, 7, 9, 10, and 12 were most strongly suppressed by multicopy expression of these virB genes. In each case, plant tumors were indistinguishable from those induced by wild-type A348 cells (Fig. 4) . Allele 8 exhibited weaker transdominance than did the other virB11* alleles, making it difficult to ascertain whether multicopy expression of virB genes suppressed the mutant phenotype. Finally, two alleles, 1 and 3, displayed strong negative dominance, and multicopy expression of any combination of virB9, virB10, or virB11 in strains expressing these alleles gave highly variable results. In some assays, these strains exhibited wild-type virulence, whereas in other assays, the same strains exhibited the same level of attenuated virulence as the corresponding A348 (pXZB1xx) strain did. The basis for this variation is not known.
In contrast to the above findings, multicopy expression of virB8 failed to suppress dominance of the class II and III alleles (Fig. 5) . In general, A348(pXZB18xx) strains exhibited the same level of virulence as did the corresponding A348 (pXZB1xx) strains. These findings show that multicopy suppression of the class II and III mutations appears to be limited to a subset of virB genes that includes virB9, virB10, and virB11 but not virB8.
Effects of multicopy expression of virB8, virB9, virB10, and/ or virB11 on VirB protein levels. Strains expressing multiple copies of virB8, virB9, virB10, and/or virB11 from the pTi and IncP plasmids were examined for VirB protein content by immunoblot analysis. As observed for multicopy expression of virB11 in A348(pXZB100) cells (Fig. 3) , multicopy expression of virB9 or virB10 was correlated with enhanced abundance of VirB9 or VirB10, respectively, compared with the levels of these proteins in wild-type A348 cells (Fig. 6) . By contrast, multicopy expression of virB8 in A348(pXZB1800) cells did not result in a detectable increase in the level of VirB8 protein over that detected in A348 cells. Plasmid pXZB1800 isolated from this strain was shown to carry the P virB ::virB8 sequence by PCR amplification and restriction enzyme analysis and to restore virulence of the ⌬virB8 strain PC1008 to levels observed previously (data not shown and references 6 and 19). As suggested by an independent line of study (23) , the stability of VirB8 and, hence, its abundance may be enhanced through an interaction with another protein(s).
These immunoblot studies further showed that cells overproducing VirB9 or VirB10 accumulated higher levels of VirB11 than A348 cells (Fig. 6, compare lanes 1, 2, 6, and 7) . Possible stabilizing effects of these VirB proteins on VirB11 have been noted previously (6, 23) . In addition, development of immunoblots with VirB10 antisera showed the presence of two small-molecular-size immunoreactive species of ϳ30 and ϳ39 kDa in extracts of cells overproducing VirB10 (Fig. 6,  lanes 3, 4, and 6 ) but two different species of ϳ19 and ϳ32 kDa in extracts of cells overproducing only VirB9 (lane 7). As suggested previously for the 39-kDa product (54), these species FIG. 4 . Suppression of virB11 mutant phenotypes by overproduction of VirB proteins. The schematic indicates the arrangement of strains inoculated at the corresponding positions on the leaves: A348, wild-type strain A348; B11*, A348 (pXZB1xx) strains expressing the virB11* alleles listed above each leaf; 9,10,11, A348(pXZB12xx) strains; 10,11, A348(pXZB13xx) strains; 11, A348(pXZB14xx) strains; 10, A348(pXZB15xx) strains; 9, A348(pXZB16xx) strains; A136, pTi plasmidless control. Leaves inoculated with strains carrying the allele 9, 1, and 3 series of plasmids show virulence of A348(pXZB17xx) strains instead of that of A136.
FIG. 5. Effects of VirB8 overproduction on virB11 mutant phenotypes. A348, wild-type strain A348; 1 to 3 and 5 to 12 and ϩB8, A348(pXZB1xx) strains expressing the virB11* alleles listed (by number) and the corresponding A348 (pXZB18xx) strains, respectively; A136, pTi plasmidless strain.
are probably proteolytic degradation products of VirB10. These findings suggest that the configuration of VirB10 at the membrane is sensitive to changes in the abundance of VirB9.
DISCUSSION
The aim of the present investigation was to genetically test for interactions between the VirB11 ATPase and other VirB proteins. The isolation of two dominant negative virB11 alleles in a previous study was considered evidence that VirB11 functions as a multimer (39) . However, that study did not rigorously exclude alternative explanations for dominant negative phenotypes (28) . For example, VirB11 could function as a monomer and the dominant negative mutants might act by sequestering the T-complex substrate or by catalytically counteracting an activity of the native protein. To further test the model that VirB11 assembles as a subunit of the T-complex transporter, we attempted to demonstrate suppression of mutant phenotypes of dominant negative virB11 alleles by overproduction of VirB proteins. Results of these studies supplied strong genetic evidence that (i) a functional T-complex transporter is composed of more than one VirB11 subunit and (ii) VirB11 undergoes complex formation with other VirB proteins, including VirB9 and VirB10.
The proposal that a functional transporter is composed of more than one VirB11 subunit derives from the isolation of the class III mutations. These mutations exhibit the intriguing property that they are phenotypically silent in PC1011 (pXZB1xx) strains lacking wild-type virB11 but display strong negative dominance in A348(pXZB1xx) merodiploid strains. These findings show that the functions of both the mutant proteins and native VirB11 are disrupted when both types of proteins are cosynthesized in the same cell. The most likely explanation for this mutant class is that VirB11 assembles as a homomultimer. If so, homomultimers of class III mutant proteins that assemble in PC1011(pXZB1xx) strains must be fully functional since these strains exhibit wild-type virulence phenotypes. By contrast, mixed multimers of native and class III mutant proteins assembled in merodiploid cells are predicted to be nonfunctional or partially functional in accordance with the attenuated virulence phenotypes of these cells. Homomultimer formation might represent an essential early step in transporter assembly, in which case mixed multimers of class III mutants and native VirB11 may be blocked for further assembly with other VirB proteins. If, as suggested by previous work (6), such interactions contribute to the stabilization of VirB11, a block in complex formation at this stage could account for the diminished abundance of VirB11 protein in virB11*/virB11 merodiploid strains compared to that in isogenic A348(pXZB100) cells (Fig. 3) .
It is noteworthy that almost all of the mutations in the class II and III alleles mapped within two discrete regions of VirB11 located near the N terminus (residues 49 to 135) and near the C terminus (residues 256 to 301). Although we do not know which of the mutations in the four double mutants and one triple mutant are responsible for the dominant phenotypes, most of the mutations in these alleles were conservative and resembled the types of substitutions that occurred in the single mutants. That is, most mutations in the dominant alleles involved substitutions of similar types of residues (e.g., nonpolar . Only four substitutions (D56G, E335G, E256G, and N73Y) involved changes in hydrophobicity, and each of these mutations was in double or triple mutants in residues that are not conserved among TraG, TrbB, and PtlH (37) . The generally conservative nature of mutations in these dominant alleles is consistent with a proposal that the regions delimited by the mutations correspond to domains that are directly involved in VirB11 oligomerization. These mutations might permit initial complex formation with a subset of other VirB proteins but disrupt the activity of the complex or its further assembly with other transporter subunits. The notion that a protein interaction domain is located in the C-terminal half of VirB11 is independently supported by our earlier finding that an allele expressing this half of the protein exerts dominance when coexpressed with wild-type virB11 (39) .
Of the dominant virB11 alleles isolated to date in this laboratory, none have possessed mutations in codons for residues within or near the Walker A nucleotide binding domain; this is true even for dominant alleles with double or triple mutations. Conversely, we (39) and others (49) have shown that mutations in codons for conserved residues in the Walker A motif are recessive. We envision two models that could account for these observations. First, ATP binding or hydrolysis may induce conformational changes in VirB11 that are required for efficient complex formation. Consistent with this model, mutant proteins with defects in the Walker A motif exhibit a stronger affinity for the cytoplasmic membrane than does native VirB11 (39) , implying that ATP may regulate VirB11 interactions with integral membrane VirB proteins or, alternatively, its insertion into the membrane. The second model is that mutant proteins with defects in ATP binding still retain the ability to oligomerize, but mixed multimers of mutant and native proteins nevertheless display a wild-type function. This could occur, for example, if one or a couple of active ATPase subunits in a multisubunit complex are sufficient for driving the transport process. Further studies are required to determine if either of these models is correct. FIG. 6 . Effects of multicopy expression of virB genes on VirB protein levels in various A348 derivatives. AS-induced cells were harvested, and cellular proteins were analyzed for VirB and VirE2 protein levels as described in the text. virB genes expressed in multicopy from an IncP replicon are listed at the top; dashes indicate no virB gene over expression. Lanes: M, molecular mass markers with sizes indicated on the left (in kilodaltons); 1, A348; 2, A348(pXZB1000); 3, A348(pXZB1200); 4, A348(pXZB1300); 5, A348(pXZB1400); 6, A348 (pXZB1500); 7, A348(pXZB1600); 8, A348(pXZB1000); 9, A348(pXZB1800).
The proposal that VirB11 associates in some fashion with VirB9 and VirB10 is supported by results of the multicopy suppression studies. Our findings are best interpreted in the context of the following information. Work in our laboratory (23, 48) and the laboratories of A. Das (1), P. Zambryski (2), and A. Binns (3) has shown that VirB7 and VirB9 assemble as a covalently cross-linked heterodimer predominantly in the outer membrane. By contrast, VirB10 is a monotopic cytoplasmic membrane protein with a small N-terminal domain in the cytoplasm (22, 53) and VirB11 resides exclusively at the cytoplasmic face of the cytoplasmic membrane (22, 39) . Two lines of evidence suggest that these proteins undergo complex formation. First, the VirB7-VirB9 heterodimer has a stabilizing effect on VirB10 and VirB11 (6, 23, 48) . Strains impaired for assembly of the VirB7-VirB9 heterodimer accumulate diminished levels of VirB10 and VirB11, whereas, conversely, strains carrying constructs that allow for the regulated synthesis of the VirB7-VirB9 heterodimer accumulate both VirB10 and VirB11 in rough proportion to the amount of heterodimer. Moreover, stabilizing effects of the heterodimer on VirB10 and VirB11 are detected in cells devoid of other VirB proteins, indicating that complex formation occurs independently of other VirB proteins (23) . Second, chemical cross-linking analyses showed that synthesis of the VirB7-VirB9 heterodimer is important for assembly of VirB10 into higher-order complexes (3). This finding and the observed effect of VirB9 overproduction on formation of presumptive VirB10 breakdown products (Fig. 6 ) strongly support the notion that VirB9 interacts with and influences the configuration of VirB10 at the cytoplasmic membrane.
Recently, the notion that these VirB proteins can form a protein subassembly gained further support. The cag pathogenicity island of H. pylori has been found to code for homologs of VirB4, VirB9, VirB10, and VirB11 (12, 18, 50) , as well as a lipoprotein which may supply a function analogous to that of VirB7 (17a). The observation that the cag pathogenicity island codes for no other VirB homologs raises the intriguing possibility that the subset of five VirB proteins listed above and homologous proteins in different bacteria comprise core structures in the cell envelope that are appropriated for use in the further assembly of dedicated macromolecular transporters (17, 18) .
The isolation of suppressors of dominant mutations has been successfully used to gain evidence for interactions among components of macromolecular surface structures such as the E. coli translocation machinery (44) and flagellar motor (27) . Multicopy suppression often is explained in terms of sequestration of a mutant protein through its interaction with an overproduced protein and, as such, is offered as evidence for a protein-protein interaction between native forms of both proteins (51) . A cautious interpretation of our suppression data is that VirB9, VirB10, and VirB11 are all interactive components of a VirB protein complex. Given the proposed localizations of these VirB proteins, we further suggest that VirB9 overproduction probably does not suppress phenotypes of the dominant virB11 alleles as a consequence of a direct interaction with mutant VirB11 proteins but rather by stabilizing a third, interfacing VirB protein. We predict that this interfacing protein is the integral cytoplasmic membrane protein, VirB10. Multicopy expression of virB9 or virB10 potentially has the combined effect of sequestering mutant VirB11 proteins into dead-end complexes while still allowing for assembly of wild-type proteins into functional transporters. Similarly, wild-type VirB11 synthesized in abundance may sequester the mutant proteins or simply outcompete the mutant proteins for interactions with other transporter subunits.
In summary, we propose a model that depicts the assembly of the T-complex transporter as an ordered process. Early in the assembly process, a VirB subcomplex that minimally consists of the VirB7-VirB9 heterodimer and VirB10 of unknown stoichiometries and more than one subunit of VirB11 must be formed. This VirB protein subcomplex then functions as a nucleation center for assembly of two structures required for transport, a transenvelope translocation channel and an extracellular pilus (16) . Interestingly, the view that VirB9, VirB10, and VirB11 act together to promote T-complex transporter assembly was independently derived several years ago by Ward et al. (52) . These investigators made the intriguing discovery that the presence of an IncQ plasmid in an otherwise-wild-type A348 strain suppresses T-DNA transfer to plants. Furthermore, the coordinate overexpression of virB9, virB10, and virB11 was shown to restore T-DNA transfer efficiencies to wild-type levels (52) . To explain these findings, it was proposed that IncQ plasmid and T-complex substrates compete for the same transporters and that overproduction of VirB9, VirB10, and VirB11 somehow favors T-DNA transfer efficiencies. One mechanism consistent with the data is that these proteins form a VirB subcomplex that is rate limiting for transporter assembly. Of further interest, Ward et al. (52) postulated that the VirB9, VirB10, and VirB11 protein complex binds substrate; if so, it is interesting to speculate that such an interaction is an important prerequisite for assembly of a functional transporter.
